Catalyst
Slingshot members are tracking this event:
DBV Technologies (DBVT) Expects to Complete Phase IIb OLFUS-VIPES Trial Evaluating Viaskin Peanut in Treatment of Peanut Allergies in August 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DBVT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 04, 2016
Occurred Source:
https://clinicaltrials.gov/archive/NCT01955109/2016_10_04/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase Iib Trial Completion, Olfus-vipes Trial, Viaskin Peanut, Peanut Allergies
